Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Atypical antipsychotic use in patients with dementia: managing safety concerns.

Steinberg M, Lyketsos CG.

Am J Psychiatry. 2012 Sep;169(9):900-6. doi: 10.1176/appi.ajp.2012.12030342.

2.
3.

The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.

Ma H, Huang Y, Cong Z, Wang Y, Jiang W, Gao S, Zhu G.

J Alzheimers Dis. 2014;42(3):915-37. doi: 10.3233/JAD-140579.

PMID:
25024323
4.

Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.

Greenblatt HK, Greenblatt DJ.

J Clin Pharmacol. 2016 Sep;56(9):1048-57. doi: 10.1002/jcph.731. Epub 2016 Apr 29. Review.

PMID:
26953213
5.

Behavioral disturbances of dementia.

Pollock BG, Mulsant BH.

J Geriatr Psychiatry Neurol. 1998 Winter;11(4):206-12. Review.

PMID:
10231000
6.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
7.

Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

Herrmann N, Lanctôt KL.

Drug Saf. 2006;29(10):833-43. Review.

PMID:
16970508
8.
9.

Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.

Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007726. doi: 10.1002/14651858.CD007726.pub2. Review.

PMID:
23543555
10.

Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.

Gareri P, De Fazio P, Manfredi VG, De Sarro G.

J Clin Psychopharmacol. 2014 Feb;34(1):109-23. doi: 10.1097/JCP.0b013e3182a6096e. Review.

PMID:
24158020
11.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
12.

Alternatives to atypical antipsychotics for the management of dementia-related agitation.

Passmore MJ, Gardner DM, Polak Y, Rabheru K.

Drugs Aging. 2008;25(5):381-98. Review.

PMID:
18447403
13.

Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?

Gurevich A, Guller V, Berner YN, Tal S.

J Nutr Health Aging. 2012;16(6):557-61. Review.

PMID:
22659997
14.

Update on neuropsychiatric symptoms of dementia: antipsychotic use.

Kalapatapu RK, Schimming C.

Geriatrics. 2009 May;64(5):10-8.

PMID:
19435390
15.

Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.

Lawlor BA.

J Clin Psychiatry. 2004;65 Suppl 11:5-10. Review.

PMID:
15264965
16.

Pharmacotherapy for behavioral and psychological symptoms of dementia in the elderly.

Beier MT.

Am J Health Syst Pharm. 2007 Jan 15;64(2 Suppl 1):S9-17; quiz S24-5.

PMID:
17215476
17.
18.

Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.

Seitz DP, Gill SS, Herrmann N, Brisbin S, Rapoport MJ, Rines J, Wilson K, Le Clair K, Conn DK.

Int Psychogeriatr. 2013 Feb;25(2):185-203. doi: 10.1017/S1041610212001627. Epub 2012 Oct 19. Review.

19.

Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications.

Kales HC, Valenstein M, Kim HM, McCarthy JF, Ganoczy D, Cunningham F, Blow FC.

Am J Psychiatry. 2007 Oct;164(10):1568-76; quiz 1623.

PMID:
17898349
20.

Risperidone for the treatment of neuropsychiatric features in dementia.

Burns A, De Deyn PP.

Drugs Aging. 2006;23(11):887-96. Review.

PMID:
17109567

Supplemental Content

Support Center